On the public citation graph

Virus-like particles in vaccine development

https://doi.org/10.1586/erv.10.115

0 signed · 1095 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1097-0290(19981105)60:3<369::aid-bit14>3.0.co;2-hopenalex-snapshot

Synthesis of rotavirus-like particles in insect cells: Comparative and quantitative analysis

inferredcites →https://doi.org/10.1002/(sici)1097-0290(19981120)60:4<408::aid-bit2>3.0.co;2-qopenalex-snapshot

Optimization of the production of virus-like particles in insect cells

inferredcites →https://doi.org/10.1002/(sici)1097-4660(199806)72:2<149::aid-jctb886>3.0.co;2-copenalex-snapshot

Production and quality analysis of Pr55gag particles produced in baculovirus-infected insect cells

inferredcites →https://doi.org/10.1002/1521-4141(200211)32:11<3305::aid-immu3305>3.0.co;2-jopenalex-snapshot

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation

inferredcites →https://doi.org/10.1002/biot.200900267openalex-snapshot

Swine‐origin pandemic H1N1 influenza virus‐like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice

inferredcites →https://doi.org/10.1002/bit.10444openalex-snapshot

Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form

inferredcites →https://doi.org/10.1002/bit.10644openalex-snapshot

Large‐scale propagation of a replication‐defective adenovirus vector in stirred‐tank bioreactor PER.C6™ cell culture under sparging conditions

inferredcites →https://doi.org/10.1002/bit.10773openalex-snapshot

Virus‐like particle production at low multiplicities of infection with the baculovirus insect cell system

inferredcites →https://doi.org/10.1002/bit.1170openalex-snapshot

Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus‐like particles by baculovirus co‐infection: Deterministic predictions and experimental results

inferredcites →https://doi.org/10.1002/bit.20385openalex-snapshot

Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells

inferredcites →https://doi.org/10.1002/bit.21518openalex-snapshot

Versatile RHDV virus‐like particles: Incorporation of antigens by genetic modification and chemical conjugation

inferredcites →https://doi.org/10.1002/bit.21716openalex-snapshot

Escherichia coli‐based cell‐free synthesis of virus‐like particles

inferredcites →https://doi.org/10.1002/bit.22125openalex-snapshot

In situ 2D fluorometry and chemometric monitoring of mammalian cell cultures

inferredcites →https://doi.org/10.1002/bit.22299openalex-snapshot

A DNA replicon system for rapid high‐level production of virus‐like particles in plants

inferredcites →https://doi.org/10.1002/bit.22364openalex-snapshot

Cell density effect in the baculovirus‐insect cells system: A quantitative analysis of energetic metabolism

inferredcites →https://doi.org/10.1002/bit.22430openalex-snapshot

Impact of physicochemical parameters on in vitro assembly and disassembly kinetics of recombinant triple‐layered rotavirus‐like particles

inferredcites →https://doi.org/10.1002/bit.260430907openalex-snapshot

Baculovirus expression system scaleup by perfusion of high‐density Sf‐9 cell cultures

inferredcites →https://doi.org/10.1002/bit.260440607openalex-snapshot

Modeling and optimization of the baculovirus expression vector system in batch suspension culture

inferredcites →https://doi.org/10.1002/btpr.187openalex-snapshot

Optimization of chimeric HIV‐1 virus‐like particle production in a baculovirus‐insect cell expression system

inferredcites →https://doi.org/10.1002/btpr.25openalex-snapshot

Towards purification of adenoviral vectors based on membrane technology

inferredcites →https://doi.org/10.1002/btpr.307openalex-snapshot

Exploiting the intracellular compartmentalization characteristics of the S. cerevisiae host cell for enhancing primary purification of lipid‐envelope virus‐like particles

inferredcites →https://doi.org/10.1002/cbic.201000094openalex-snapshot

Low pH‐Triggered Model Drug Molecule Release from Virus‐Like Particles

inferredcites →https://doi.org/10.1002/eji.200526285openalex-snapshot

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity

inferredcites →https://doi.org/10.1002/eji.200737989openalex-snapshot

Active immunization with IL‐1 displayed on virus‐like particles protects from autoimmune arthritis

inferredcites →https://doi.org/10.1002/jgm.1021openalex-snapshot

Scaleable purification process for gene therapy retroviral vectors

inferredcites →https://doi.org/10.1002/jmv.20228openalex-snapshot

E. coli‐expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability

inferredcites →https://doi.org/10.1002/jmv.20762openalex-snapshot

Norovirus capsid protein expressed in yeast forms virus‐like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

inferredcites →https://doi.org/10.1002/jps.20493openalex-snapshot

Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

inferredcites →https://doi.org/10.1002/rmv.449openalex-snapshot

Virus-like particles as HIV-1 vaccines

inferredcites →https://doi.org/10.1002/yea.320070502openalex-snapshot

Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha

inferredcites →https://doi.org/10.1006/jmbi.1997.1258openalex-snapshot

Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles

inferredcites →https://doi.org/10.1006/jmbi.2000.3723openalex-snapshot

Large conformational changes in the maturation of a simple RNA virus, Nudaurelia capensis ω virus (NωV) 1 1Edited by D. Rees

inferredcites →https://doi.org/10.1006/prep.2000.1335openalex-snapshot

Effect of Copy Number on the Expression Levels of Hepatitis B Surface Antigen in the Methylotrophic Yeast Pichia pastoris

inferredcites →https://doi.org/10.1006/viro.1995.1054openalex-snapshot

Assembly of the T = 4 Nudaurelia capensis ω Virus Capsid Protein, Post-Translational Cleavage, and Specific Encapsidation of Its mRNA in a Baculovirus Expression System

inferredcites →https://doi.org/10.1006/viro.1995.9955openalex-snapshot

Assembly of SIV Virus-like Particles Containing Envelope Proteins Using a Baculovirus Expression System

inferredcites →https://doi.org/10.1006/viro.1998.9050openalex-snapshot

Expression of Human Papillomavirus Type 16 L1 Protein inEscherichia coli:Denaturation, Renaturation, and Self-Assembly of Virus-like Particlesin Vitro

inferredcites →https://doi.org/10.1006/viro.1999.0120openalex-snapshot

Expression of Human Immunodeficiency Virus Type 1 Gag Protein Precursor and Envelope Proteins from a Vesicular Stomatitis Virus Recombinant: High-Level Production of Virus-like Particles Containing HIV Envelope

inferredcites →https://doi.org/10.1006/viro.2000.0435openalex-snapshot

Papillomavirus Virus-like Particles for the Delivery of Multiple Cytotoxic T Cell Epitopes

inferredcites →https://doi.org/10.1006/viro.2001.1240openalex-snapshot

Chimeric Recombinant Hepatitis E Virus-like Particles as an Oral Vaccine Vehicle Presenting Foreign Epitopes

inferredcites →https://doi.org/10.1006/viro.2002.1589openalex-snapshot

Chimeric Human Papilloma Virus–Simian/Human Immunodeficiency Virus Virus-like-Particle Vaccines: Immunogenicity and Protective Efficacy in Macaques

inferredcites →https://doi.org/10.1006/viro.2002.1610openalex-snapshot

Production of Hybrid Double- or Triple-Layered Virus-Like Particles of Group A and C Rotaviruses Using a Baculovirus Expression System

inferredcites →https://doi.org/10.1007/1-4020-3103-3_12openalex-snapshot

Intracellular Nucleotide Pools for Optimizing Product-Oriented Transient Transfection of Hek293 Cells in Suspension

inferredcites →https://doi.org/10.1007/978-1-59745-457-5_14openalex-snapshot

Virus-like Particle and Viral Vector Production Using the Baculovirus Expression Vector System/Insect Cell System

inferredcites →https://doi.org/10.1007/bf00180634openalex-snapshot

Growth rate control in fed-batch cultures of recombinant Saccharomyces cerevisiae producing hepatitis B surface antigen (HBsAg)

inferredcites →https://doi.org/10.1007/bf01026994openalex-snapshot

A continuous process for the production of baculovirus using insect-cell cultures

inferredcites →https://doi.org/10.1007/bf01311047openalex-snapshot

Production of hepatitis B virus surface antigen containing pre-S1 and pre-S2 domains by Chinese hamster ovary cells

inferredcites →https://doi.org/10.1007/bf01314870openalex-snapshot

Rapid purification of extracellular and intracellular Moloney murine leukemia virus

inferredcites →https://doi.org/10.1007/bf01974539openalex-snapshot

Immunogenicity of a recombinant pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster

inferredcites →https://doi.org/10.1007/bf02634086openalex-snapshot

Intrinsic glycosylation potentials of insect cell cultures and insect larvae

inferredcites →https://doi.org/10.1007/s00253-002-0976-xopenalex-snapshot

Large scale production and downstream processing of a recombinant porcine parvovirus vaccine

inferredcites →https://doi.org/10.1007/s00253-006-0812-9openalex-snapshot

Increased Hepatitis B surface antigen production by recombinant Aspergillus niger through the optimization of agitation and dissolved oxygen concentration

inferredcites →https://doi.org/10.1007/s00262-004-0655-0openalex-snapshot

Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma

inferredcites →https://doi.org/10.1007/s00449-002-0289-6openalex-snapshot

The production of human papillomavirus type 16 L1 vaccine product from Escherichia coli inclusion bodies

inferredcites →https://doi.org/10.1007/s00705-005-0517-xopenalex-snapshot

Generation of recombinant Norovirus-like particles (VLP) in the human endothelial kidney cell line 293T

inferredcites →https://doi.org/10.1007/s00705-009-0336-6openalex-snapshot

Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli

inferredcites →https://doi.org/10.1007/s00705-009-0484-8openalex-snapshot

Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris

inferredcites →https://doi.org/10.1007/s11373-007-9204-0openalex-snapshot

Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2

inferredcites →https://doi.org/10.1007/s12033-008-9051-xopenalex-snapshot

Transient Transfection Factors for High-Level Recombinant Protein Production in Suspension Cultured Mammalian Cells

inferredcites →https://doi.org/10.1007/s12033-010-9268-3openalex-snapshot

Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

inferredcites →https://doi.org/10.1016/0042-6822(90)90194-vopenalex-snapshot

Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV

inferredcites →https://doi.org/10.1016/0141-0229(94)00071-xopenalex-snapshot

Serum-free and serum-containing media for growth of suspended BHK aggregates in stirred vessels

inferredcites →https://doi.org/10.1016/0168-1656(96)00003-xopenalex-snapshot

Kinetic analysis of alkaline protease activity, recombinant protein production and metabolites for infected insect (Sf9) cells under different DO levels

inferredcites →https://doi.org/10.1016/0168-1702(95)00053-sopenalex-snapshot

Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus

inferredcites →https://doi.org/10.1016/0264-410x(94)00061-qopenalex-snapshot

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

inferredcites →https://doi.org/10.1016/j.ab.2007.03.033openalex-snapshot

A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors

inferredcites →https://doi.org/10.1016/j.ab.2008.02.011openalex-snapshot

Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering

inferredcites →https://doi.org/10.1016/j.bbrc.2005.12.001openalex-snapshot

Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus

inferredcites →https://doi.org/10.1016/j.biotechadv.2009.05.003openalex-snapshot

Advances in on-line monitoring and control of mammalian cell cultures: Supporting the PAT initiative

inferredcites →https://doi.org/10.1016/j.chroma.2008.03.035openalex-snapshot

Sodium dodecyl sulfate-capillary gel electrophoresis analysis of rotavirus-like particles

inferredcites →https://doi.org/10.1016/j.colsurfb.2008.09.017openalex-snapshot

Comparison of different commercially available cationic liposome–DNA lipoplexes: Parameters influencing toxicity and transfection efficiency

inferredcites →https://doi.org/10.1016/j.compchemeng.2007.04.017openalex-snapshot

Stochastic simulation of protein expression in the baculovirus/insect cells system

inferredcites →https://doi.org/10.1016/j.copbio.2007.10.013openalex-snapshot

Virus-like particles—universal molecular toolboxes

inferredcites →https://doi.org/10.1016/j.febslet.2004.09.009openalex-snapshot

Efficient assembly and release of SARS coronavirus‐like particles by a heterologous expression system

inferredcites →https://doi.org/10.1016/j.jalz.2008.05.295openalex-snapshot

S2‐04–06: Safety, tolerability and immunogenicity of the Aβ immunotherapeutic vaccine CAD106 in a first‐in‐man study in Alzheimer patients

inferredcites →https://doi.org/10.1016/j.jbiotec.2003.09.012openalex-snapshot

Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity

inferredcites →https://doi.org/10.1016/j.jbiotec.2005.01.010openalex-snapshot

Production in Saccharomyces cerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs

inferredcites →https://doi.org/10.1016/j.jbiotec.2005.02.018openalex-snapshot

Baculovirus-mediated production of HDV-like particles in BHK cells using a novel oscillating bioreactor

inferredcites →https://doi.org/10.1016/j.jbiotec.2005.03.009openalex-snapshot

Effect of refeed strategies and non-ammoniagenic medium on adenovirus production at high cell densities

inferredcites →https://doi.org/10.1016/j.jbiotec.2005.03.026openalex-snapshot

Triple layered rotavirus VLP production: Kinetics of vector replication, mRNA stability and recombinant protein production

inferredcites →https://doi.org/10.1016/j.jbiotec.2006.01.037openalex-snapshot

The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: Predictability and efficiency by transgene exchange

inferredcites →https://doi.org/10.1016/j.jbiotec.2006.08.002openalex-snapshot

Downstream processing of triple layered rotavirus like particles

inferredcites →https://doi.org/10.1016/j.jbiotec.2007.01.010openalex-snapshot

Effect of ammonia production on intracellular pH: Consequent effect on adenovirus vector production

inferredcites →https://doi.org/10.1016/j.jbiotec.2008.05.012openalex-snapshot

Presentation of functional foreign peptides on the surface of SV40 virus-like particles

inferredcites →https://doi.org/10.1016/j.jchromb.2005.07.034openalex-snapshot

Quantification of rotavirus-like particles by gel permeation chromatography

inferredcites →https://doi.org/10.1016/j.jchromb.2006.03.064openalex-snapshot

Molecular characterization of recombinant Hepatitis B surface antigen from Chinese hamster ovary and Hansenula polymorpha cells by high-performance size exclusion chromatography and multi-angle laser light scattering

inferredcites →https://doi.org/10.1016/j.jchromb.2008.09.002openalex-snapshot

Purification of recombinant rotavirus VP7 glycoprotein for the study of in vitro rotavirus-like particles assembly

inferredcites →https://doi.org/10.1016/j.jneumeth.2006.05.017openalex-snapshot

pH dependent high transfection efficiency of mouse neuroblastomas using TransFectin

inferredcites →https://doi.org/10.1016/j.jsb.2008.12.002openalex-snapshot

Heparin binding induces conformational changes in Adeno-associated virus serotype 2

inferredcites →https://doi.org/10.1016/j.jviromet.2005.02.015openalex-snapshot

Analysis of Ebola virus and VLP release using an immunocapture assay

inferredcites →https://doi.org/10.1016/j.jviromet.2007.09.002openalex-snapshot

Production of rotavirus-like particles in Spodoptera frugiperda larvae

inferredcites →https://doi.org/10.1016/j.jviromet.2008.05.025openalex-snapshot

Recombinant hepatitis B virus core particles: Association, dissociation and encapsidation of green fluorescent protein

inferredcites →https://doi.org/10.1016/j.jviromet.2010.03.003openalex-snapshot

Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis

inferredcites →https://doi.org/10.1016/j.memsci.2007.12.021openalex-snapshot

Anion-exchange membrane chromatography for purification of rotavirus-like particles

inferredcites →https://doi.org/10.1016/j.molimm.2004.06.028openalex-snapshot

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses

inferredcites →https://doi.org/10.1016/j.patbio.2010.01.006openalex-snapshot

Hepatitis B vaccines: Protective efficacy and therapeutic potential

inferredcites →https://doi.org/10.1016/j.pep.2008.01.021openalex-snapshot

Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae

inferredcites →https://doi.org/10.1016/j.procbio.2007.05.004openalex-snapshot

Production of adenoviral vectors and its recovery

inferredcites →https://doi.org/10.1016/j.procbio.2008.02.012openalex-snapshot

Enhanced intracellular accumulation of recombinant HBsAg in CHO cells by dimethyl sulfoxide

inferredcites →https://doi.org/10.1016/j.talanta.2009.06.081openalex-snapshot

Monitoring virus-like particle and viral protein production by intact cell MALDI-TOF mass spectrometry

inferredcites →https://doi.org/10.1016/j.vaccine.2004.05.013openalex-snapshot

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia

inferredcites →https://doi.org/10.1016/j.vaccine.2004.11.017openalex-snapshot

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses

inferredcites →https://doi.org/10.1016/j.vaccine.2004.11.020openalex-snapshot

Challenges in creating a vaccine to prevent hepatitis E

inferredcites →https://doi.org/10.1016/j.vaccine.2004.11.070openalex-snapshot

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

inferredcites →https://doi.org/10.1016/j.vaccine.2005.07.098openalex-snapshot

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice

inferredcites →https://doi.org/10.1016/j.vaccine.2005.09.001openalex-snapshot

Prophylactic HPV vaccines: Reducing the burden of HPV-related diseases

inferredcites →https://doi.org/10.1016/j.vaccine.2005.12.024openalex-snapshot

Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice

inferredcites →https://doi.org/10.1016/j.vaccine.2006.02.051openalex-snapshot

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV)

inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.059openalex-snapshot

Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-β without concomitant T cell responses

inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.111openalex-snapshot

Chapter 2: The burden of HPV-related cancers

inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.128openalex-snapshot

Chapter 15: HPV vaccine use in the developing world.

inferredcites →https://doi.org/10.1016/j.vaccine.2006.11.049openalex-snapshot

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11

inferredcites →https://doi.org/10.1016/j.vaccine.2007.01.085openalex-snapshot

Measurement of malaria vaccine efficacy in phase III trials: Report of a WHO consultation

inferredcites →https://doi.org/10.1016/j.vaccine.2007.01.106openalex-snapshot

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

inferredcites →https://doi.org/10.1016/j.vaccine.2007.02.059openalex-snapshot

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza

inferredcites →https://doi.org/10.1016/j.vaccine.2007.09.016openalex-snapshot

Advances in methods for the production, purification, and characterization of HIV-1 Gag–Env pseudovirion vaccines

inferredcites →https://doi.org/10.1016/j.vaccine.2008.06.002openalex-snapshot

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

inferredcites →https://doi.org/10.1016/j.vaccine.2008.07.084openalex-snapshot

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses

inferredcites →https://doi.org/10.1016/j.vaccine.2008.11.011openalex-snapshot

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

inferredcites →https://doi.org/10.1016/j.vaccine.2009.01.014openalex-snapshot

Refining HPV 16 L1 purification from E. coli: Reducing endotoxin contaminations and their impact on immunogenicity

inferredcites →https://doi.org/10.1016/j.vaccine.2009.07.007openalex-snapshot

M2e-based universal influenza A vaccine

inferredcites →https://doi.org/10.1016/j.vaccine.2009.09.093openalex-snapshot

Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper

inferredcites →https://doi.org/10.1016/j.virol.2004.06.047openalex-snapshot

Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant

inferredcites →https://doi.org/10.1016/j.virol.2005.04.004openalex-snapshot

Universal influenza A vaccine: Optimization of M2-based constructs

inferredcites →https://doi.org/10.1016/j.virol.2008.09.020openalex-snapshot

Protection against lethal challenge by Ebola virus-like particles produced in insect cells

inferredcites →https://doi.org/10.1016/j.virusres.2006.02.010openalex-snapshot

Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests

inferredcites →https://doi.org/10.1016/j.virusres.2009.04.005openalex-snapshot

Influenza vaccines based on virus-like particles

inferredcites →https://doi.org/10.1016/j.ymben.2006.08.006openalex-snapshot

Transcriptional profiling of batch and fed-batch protein-free 293-HEK cultures

inferredcites →https://doi.org/10.1016/j.ymben.2009.08.008openalex-snapshot

Improving baculovirus production at high cell density through manipulation of energy metabolism

inferredcites →https://doi.org/10.1016/j.ymeth.2003.11.002openalex-snapshot

FuGENE 6 Transfection Reagent: the gentle power

inferredcites →https://doi.org/10.1016/j.ymeth.2006.07.018openalex-snapshot

Virus-like particles: Passport to immune recognition

inferredcites →https://doi.org/10.1016/s0006-3495(91)82181-6openalex-snapshot

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction

inferredcites →https://doi.org/10.1016/s0021-9258(17)38948-2openalex-snapshot

Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli.

inferredcites →https://doi.org/10.1016/s0042-6822(02)00134-4openalex-snapshot

Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope

inferredcites →https://doi.org/10.1016/s0042-6822(03)00372-6openalex-snapshot

Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles

inferredcites →https://doi.org/10.1016/s0140-6736(08)60381-5openalex-snapshot

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

inferredcites →https://doi.org/10.1016/s0163-4453(97)92814-0openalex-snapshot

A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects

inferredcites →https://doi.org/10.1016/s0166-3542(00)00136-4openalex-snapshot

High efficient production of Pr55gag virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A

inferredcites →https://doi.org/10.1016/s0168-1656(02)00181-5openalex-snapshot

Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen

inferredcites →https://doi.org/10.1016/s0168-1656(99)00201-1openalex-snapshot

Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris

inferredcites →https://doi.org/10.1016/s0168-8278(00)00082-9openalex-snapshot

Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine

inferredcites →https://doi.org/10.1016/s0264-410x(00)00259-0openalex-snapshot

Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles

inferredcites →https://doi.org/10.1016/s0264-410x(01)00312-7openalex-snapshot

Antibody responses to preS components after immunization of children with low doses of BioHepB

inferredcites →https://doi.org/10.1016/s0264-410x(02)00266-9openalex-snapshot

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

inferredcites →https://doi.org/10.1016/s0264-410x(02)00569-8openalex-snapshot

Therapeutic vaccination for future management of HIV/AIDS

inferredcites →https://doi.org/10.1016/s0378-1119(96)00647-6openalex-snapshot

Polypeptides of hepatitis B surface antigen produced in transgenic potato

inferredcites →https://doi.org/10.1016/s0966-842x(03)00208-7openalex-snapshot

Virus-like particles as immunogens

inferredcites →https://doi.org/10.1016/s1046-5928(03)00011-1openalex-snapshot

Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line

inferredcites →https://doi.org/10.1016/s1097-2765(00)80449-9openalex-snapshot

Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16

inferredcites →https://doi.org/10.1016/s1470-2045(09)70096-8openalex-snapshot

A review of human carcinogens—Part B: biological agents

inferredcites →https://doi.org/10.1016/s1473-3099(02)00315-8openalex-snapshot

Global control of hepatitis B virus infection

inferredcites →https://doi.org/10.1016/s1521-6616(03)00120-7openalex-snapshot

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

inferredcites →https://doi.org/10.1021/bi800540bopenalex-snapshot

Virus-like Particles as Quantitative Probes of Membrane Protein Interactions

inferredcites →https://doi.org/10.1021/bi9604800openalex-snapshot

Dimorphism of Hepatitis B Virus Capsids Is Strongly Influenced by the C-Terminus of the Capsid Protein

inferredcites →https://doi.org/10.1021/bp00025a007openalex-snapshot

Continuous β‐Galactosidase Production in Insect Cells with a p10 Gene Based Baculovirus Vector in a Two‐Stage Bioreactor System

inferredcites →https://doi.org/10.1021/bp049802eopenalex-snapshot

Production of Recombinant Adeno-Associated Viral Vectors Using a Baculovirus/Insect Cell Suspension Culture System: From Shake Flasks to a 20-L Bioreactor

inferredcites →https://doi.org/10.1021/bp980021lopenalex-snapshot

Effects of Oxygen on Recombinant Protein Expression

inferredcites →https://doi.org/10.1021/ja031790qopenalex-snapshot

Interior Surface Modification of Bacteriophage MS2

inferredcites →https://doi.org/10.1038/13484openalex-snapshot

A universal influenza A vaccine based on the extracellular domain of the M2 protein

inferredcites →https://doi.org/10.1038/279043a0openalex-snapshot

Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322

inferredcites →https://doi.org/10.1038/279346a0openalex-snapshot

Cloning and endonuclease mapping of the hepatitis B viral genome

inferredcites →https://doi.org/10.1038/280815a0openalex-snapshot

Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen

inferredcites →https://doi.org/10.1038/298347a0openalex-snapshot

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

inferredcites →https://doi.org/10.1038/329068a0openalex-snapshot

The expression of hybrid HIV:Ty virus-like particles in yeast

inferredcites →https://doi.org/10.1038/gt.2009.33openalex-snapshot

Purification of recombinant baculoviruses for gene therapy using membrane processes

inferredcites →https://doi.org/10.1038/nbt0587-479openalex-snapshot

High–Level Expression and Efficient Assembly of Hepatitis B Surface Antigen in the Methylotrophic Yeast, Pichia Pastoris

inferredcites →https://doi.org/10.1038/nbt0988-1065openalex-snapshot

Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum.

inferredcites →https://doi.org/10.1038/nbt1288-1411openalex-snapshot

Scaleup of Insect Cell Cultures: Protective Effects of Pluronic F-68

inferredcites →https://doi.org/10.1038/nm1218openalex-snapshot

The process development challenge for a new vaccine

inferredcites →https://doi.org/10.1038/sj.gt.3302624openalex-snapshot

Downstream processing of viral vectors and vaccines

inferredcites →https://doi.org/10.1038/sj.mt.6300251openalex-snapshot

Functional Analysis of Various Promoters in Lentiviral Vectors at Different Stages of In Vitro Differentiation of Mouse Embryonic Stem Cells

inferredcites →https://doi.org/10.1046/j.1432-1327.1999.00241.xopenalex-snapshot

Critical relationship between glycosylation of recombinant lutropin receptor ectodomain and its secretion from baculovirus‐infected insect cells

inferredcites →https://doi.org/10.1046/j.1468-1293.2001.00080.xopenalex-snapshot

Therapeutic vaccination (p24‐VLP) of patients with advanced HIV‐1 infection in the pre‐HAART era does not alter CD4 cell decline

inferredcites →https://doi.org/10.1053/jhep.2001.26523openalex-snapshot

Hepatitis C Virus-Like Particles Induce Virus–Specific Humoral and Cellular Immune Responses in Mice

inferredcites →https://doi.org/10.1056/nejmoa065497openalex-snapshot

Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer

inferredcites →https://doi.org/10.1073/pnas.0438037100openalex-snapshot

A plant signal peptide–hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells

inferredcites →https://doi.org/10.1073/pnas.082281199openalex-snapshot

HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae

inferredcites →https://doi.org/10.1073/pnas.1832245100openalex-snapshot

Chaperone-mediated in vitro assembly of Polyomavirus capsids

inferredcites →https://doi.org/10.1073/pnas.76.5.2222openalex-snapshot

Cloning in Escherichia coli and physical structure of hepatitis B virion DNA.

inferredcites →https://doi.org/10.1073/pnas.80.1.1openalex-snapshot

Expression of hepatitis B surface antigen gene in yeast.

inferredcites →https://doi.org/10.1073/pnas.81.24.7708openalex-snapshot

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin.

inferredcites →https://doi.org/10.1073/pnas.89.24.12180openalex-snapshot

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

inferredcites →https://doi.org/10.1073/pnas.92.25.11553openalex-snapshot

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

inferredcites →https://doi.org/10.1073/pnas.93.11.5335openalex-snapshot

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

inferredcites →https://doi.org/10.1073/pnas.96.5.1915openalex-snapshot

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids

inferredcites →https://doi.org/10.1080/03079450802357001openalex-snapshot

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

inferredcites →https://doi.org/10.1084/jem.180.3.1037openalex-snapshot

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes.

inferredcites →https://doi.org/10.1086/376505openalex-snapshot

Cellular Immune Responses to Human Papillomavirus (HPV)–16 L1 in Healthy Volunteers Immunized with Recombinant HPV‐16 L1 Virus‐Like Particles

inferredcites →https://doi.org/10.1086/506361openalex-snapshot

Parvovirus B19 Empty Capsids as Antigen Carriers for Presentation of Antigenic Determinants of Dengue 2 Virus

inferredcites →https://doi.org/10.1086/520612openalex-snapshot

Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents

inferredcites →https://doi.org/10.1089/vim.2005.18.244openalex-snapshot

Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge

inferredcites →https://doi.org/10.1089/vim.2005.18.365openalex-snapshot

Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge

inferredcites →https://doi.org/10.1089/vim.2007.0027openalex-snapshot

A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1)

inferredcites →https://doi.org/10.1089/vim.2007.0031openalex-snapshot

Protective Immune Responses against Foot-and-Mouth Disease Virus by Vaccination with a DNA Vaccine Expressing Virus-Like Particles

inferredcites →https://doi.org/10.1096/fasebj.13.13.1796openalex-snapshot

A plant‐derived edible vaccine against hepatitis B virus

inferredcites →https://doi.org/10.1097/00001432-200210000-00002openalex-snapshot

New immunization initiatives and progress toward the global control of hepatitis B

inferredcites →https://doi.org/10.1097/hjh.0b013e32800ff5d6openalex-snapshot

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

inferredcites →https://doi.org/10.1099/0022-1317-69-11-2763openalex-snapshot

Co-expression of the Hepatitis B Surface and Core Antigens Using Baculovirus Multiple Expression Vectors

inferredcites →https://doi.org/10.1099/0022-1317-72-12-2981openalex-snapshot

Baculovirus Expression of the Human Papillomavirus Type 16 Capsid Proteins: Detection of L1-L2 Protein Complexes

inferredcites →https://doi.org/10.1099/0022-1317-72-3-753openalex-snapshot

Synthesis of Newcastle disease virus (NDV)-like envelopes in insect cells infected with a recombinant baculovirus expressing the haemagglutinin-neuraminidase of NDV

inferredcites →https://doi.org/10.1099/0022-1317-75-5-1101openalex-snapshot

Assembly of Herpes Simplex virus Type 1 Capsids Using a Panel of Recombinant Baculoviruses

showing the first 200 of 266 · page through all 266

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4197210openalex-extracted

Poly(I:C) and CpG Improve the Assembly of Foot-and-Mouth Disease Virus-Like Particles and Immune Response in Mice

inferred← citeshttps://doi.org/10.1001/jama.2020.2477openalex-snapshot

Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes

inferred← citeshttps://doi.org/10.1002/9781118644843.ch4openalex-snapshot

Pathogenesis of Rift Valley Fever in Humans

inferred← citeshttps://doi.org/10.1002/9781119506287.ch10openalex-snapshot

Novel Developments and Next‐Generation Vaccines

inferred← citeshttps://doi.org/10.1002/9781119858041.ch1openalex-snapshot

Nanotechnology in Vaccine Development and Constraints

inferred← citeshttps://doi.org/10.1002/9781119858041.ch18openalex-snapshot

Functionalization of Nanobiomaterials in Nanovaccinology

inferred← citeshttps://doi.org/10.1002/9783527653096.ch2openalex-snapshot

Advances in Protein Production Technologies

inferred← citeshttps://doi.org/10.1002/9783527653096.ch5openalex-snapshot

Virus‐Like Particle Bioprocessing

inferred← citeshttps://doi.org/10.1002/9783527683321.ch10openalex-snapshot

Industrial Large Scale of Suspension Culture of Insect Cells

inferred← citeshttps://doi.org/10.1002/9783527838394.ch4openalex-snapshot

Self‐Replicating RNA Viruses for Vaccine Development

inferred← citeshttps://doi.org/10.1002/adfm.202009860openalex-snapshot

Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues

inferred← citeshttps://doi.org/10.1002/adhm.201501000openalex-snapshot

Viruses, Artificial Viruses and Virus‐Based Structures for Biomedical Applications

inferred← citeshttps://doi.org/10.1002/adhm.201700930openalex-snapshot

Progress Toward the Clinical Translation of Bioinspired Peptide and Protein Assemblies

inferred← citeshttps://doi.org/10.1002/adhm.201701395openalex-snapshot

Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections

inferred← citeshttps://doi.org/10.1002/adhm.201801546openalex-snapshot

The Growing Development of DNA Nanostructures for Potential Healthcare‐Related Applications

inferred← citeshttps://doi.org/10.1002/adhm.202001812openalex-snapshot

Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery

inferred← citeshttps://doi.org/10.1002/adhm.202300224openalex-snapshot

Engineered Curli Nanofilaments as a Self‐Adjuvanted Antigen Delivery Platform

inferred← citeshttps://doi.org/10.1002/adhm.202302755openalex-snapshot

Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate

inferred← citeshttps://doi.org/10.1002/adma.201901255openalex-snapshot

Biomimetic Nanotechnology toward Personalized Vaccines

inferred← citeshttps://doi.org/10.1002/adma.202005927openalex-snapshot

Advanced Nanomaterials for Preparedness Against (Re‐)Emerging Viral Diseases

inferred← citeshttps://doi.org/10.1002/adtp.202000173openalex-snapshot

Management of Coronavirus Disease 2019 (COVID‐19) Pandemic: From Diagnosis to Treatment Strategies

inferred← citeshttps://doi.org/10.1002/adtp.202100072openalex-snapshot

Nanotoxoids: Biomimetic Nanoparticle Vaccines against Infections

inferred← citeshttps://doi.org/10.1002/bab.2076openalex-snapshot

A review of COVID‐19 vaccines and major considerations for diabetic patients

inferred← citeshttps://doi.org/10.1002/bies.201200057openalex-snapshot

Improved vaccines through targeted manipulation of the body's immunological risk‐assessment?

inferred← citeshttps://doi.org/10.1002/biot.201400427openalex-snapshot

Enveloped virus‐like particles as vaccines against pathogenic arboviruses

inferred← citeshttps://doi.org/10.1002/biot.201400428openalex-snapshot

Plant‐made vaccines against West Nile virus are potent, safe, and economically feasible

inferred← citeshttps://doi.org/10.1002/bip.22759openalex-snapshot

Different applications of virus‐like particles in biology and medicine: Vaccination and delivery systems

inferred← citeshttps://doi.org/10.1002/bit.24907openalex-snapshot

Effects of pre‐existing anti‐carrier immunity and antigenic element multiplicity on efficacy of a modular virus‐like particle vaccine

inferred← citeshttps://doi.org/10.1002/bit.25159openalex-snapshot

Bioengineering virus‐like particles as vaccines

inferred← citeshttps://doi.org/10.1002/bit.26367openalex-snapshot

Intracellular characterization of Gag VLP production by transient transfection of HEK 293 cells

inferred← citeshttps://doi.org/10.1002/bit.26890openalex-snapshot

Synthetic biology for bioengineering virus‐like particle vaccines

inferred← citeshttps://doi.org/10.1002/bit.27766openalex-snapshot

Integrating high cell density cultures with adapted laboratory evolution for improved Gag‐HA virus‐like particles production in stable insect cell lines

inferred← citeshttps://doi.org/10.1002/bit.28051openalex-snapshot

Differential N‐ and O‐glycosylation signatures of HIV‐1 Gag virus‐like particles and coproduced extracellular vesicles

inferred← citeshttps://doi.org/10.1002/bit.28785openalex-snapshot

Development and qualification of 3 L scale‐down model for large scale vaccine process on Vero cell culture using microcarriers

inferred← citeshttps://doi.org/10.1002/bit.70346openalex-snapshot

Purification of Disassembled Capsid Protein by Hydroxyapatite Chromatography Enhances Virus‐Like Particle Recovery

inferred← citeshttps://doi.org/10.1002/btm2.10421openalex-snapshot

Micro and nanotechnologies: The little formulations that could

inferred← citeshttps://doi.org/10.1002/btpr.1842openalex-snapshot

Protein production using the baculovirus‐insect cell expression system

inferred← citeshttps://doi.org/10.1002/btpr.2224openalex-snapshot

Optimization of norovirus virus‐like particle production in Pichia pastoris using a real‐time near‐infrared bioprocess monitor

inferred← citeshttps://doi.org/10.1002/btpr.2921openalex-snapshot

Using a noninfectious MVM surrogate for assessing viral clearance during downstream process development

inferred← citeshttps://doi.org/10.1002/btpr.3318openalex-snapshot

Real‐time online monitoring of insect cell proliferation and baculovirus infection using digital differential holographic microscopy and machine learning

inferred← citeshttps://doi.org/10.1002/cpz1.55openalex-snapshot

VLP‐factory™ and ADDomer©: Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display

inferred← citeshttps://doi.org/10.1002/cpz1.575openalex-snapshot

Using the Sleeping Beauty (SB) Transposon to Generate Stable Cells Producing Enveloped Virus‐Like Particles (eVLPs) Pseudotyped with SARS‐CoV‐2 Proteins for Vaccination

inferred← citeshttps://doi.org/10.1002/ctm2.1384openalex-snapshot

mRNA vaccine in cancer therapy: Current advance and future outlook

inferred← citeshttps://doi.org/10.1002/elsc.201300093openalex-snapshot

Fully aseptic single‐use cross flow filtration system for clarification and concentration of cytomegalovirus‐like particles

inferred← citeshttps://doi.org/10.1002/elsc.202000033openalex-snapshot

Characterization and stabilization in process development and product formulation for super large proteinaceous particles

inferred← citeshttps://doi.org/10.1002/jbio.202500461openalex-snapshot

Application of Super‐Resolution Microscopy in Virology Research: Principles, Technological Advances, and Analysis of the Viral Life Cycle

inferred← citeshttps://doi.org/10.1002/jcp.28339openalex-snapshot

Induction of protective immune response to intranasal administration of influenza virus‐like particles in a mouse model

inferred← citeshttps://doi.org/10.1002/jctb.5777openalex-snapshot

Extended gene expression for Gag VLP production achieved at bioreactor scale

inferred← citeshttps://doi.org/10.1002/jctb.6821openalex-snapshot

Current status and future challenges in transitioning to continuous bioprocessing of virus‐like particles

inferred← citeshttps://doi.org/10.1002/jctb.70183openalex-snapshot

Media‐dependent performance of rabies virus‐like particle production under low oxygen tension in baculovirus‐infected Sf9 cells

inferred← citeshttps://doi.org/10.1002/jev2.12438openalex-snapshot

Cell‐engineered virus‐mimetic nanovesicles for vaccination against enveloped viruses

inferred← citeshttps://doi.org/10.1002/jmv.28622openalex-snapshot

Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens

inferred← citeshttps://doi.org/10.1002/jps.22618openalex-snapshot

Multidimensional methods for the formulation of biopharmaceuticals and vaccines

inferred← citeshttps://doi.org/10.1002/jps.24273openalex-snapshot

Multivalent Nanomaterials: Learning from Vaccines and Progressing to Antigen-Specific Immunotherapies

inferred← citeshttps://doi.org/10.1002/jssc.202100891openalex-snapshot

Comparison of the separation of proteins of wide‐ranging molecular weight via trilobal polypropylene capillary‐channeled polymer fiber, commercial superficiously porous, and commercial size exclusion columns

inferred← citeshttps://doi.org/10.1002/jssc.202100947openalex-snapshot

Downstream processing of virus‐like particles with aqueous two‐phase systems: Applications and challenges

inferred← citeshttps://doi.org/10.1002/mas.21571openalex-snapshot

The expanding role of mass spectrometry in the field of vaccine development

inferred← citeshttps://doi.org/10.1002/mco2.720openalex-snapshot

Synthetic circRNA therapeutics: innovations, strategies, and future horizons

inferred← citeshttps://doi.org/10.1002/pro.2953openalex-snapshot

Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus‐like particle

inferred← citeshttps://doi.org/10.1002/rmv.1709openalex-snapshot

The ongoing pursuit of a prophylactic HSV vaccine

inferred← citeshttps://doi.org/10.1002/rmv.1954openalex-snapshot

Rotavirus virus‐like particles (RV‐VLPs) vaccines: An update

inferred← citeshttps://doi.org/10.1002/rmv.2361openalex-snapshot

Insight into the Enterovirus A71: A review

inferred← citeshttps://doi.org/10.1002/rmv.70139openalex-snapshot

Virus‐Like Nanoparticles for Vaccine Development and Drug Delivery

inferred← citeshttps://doi.org/10.1002/smll.202300125openalex-snapshot

Site‐Specific Modification of Virus‐Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity

inferred← citeshttps://doi.org/10.1002/smll.202303713openalex-snapshot

Novel Vectors and Administrations for mRNA Delivery

inferred← citeshttps://doi.org/10.1002/wnan.1579openalex-snapshot

Virus‐like particles for vaccination against cancer

inferred← citeshttps://doi.org/10.1002/wnan.1646openalex-snapshot

Biogenic nanoparticles as immunomodulator for tumor treatment

inferred← citeshttps://doi.org/10.1007/10_2013_186openalex-snapshot

Fast Single-Use VLP Vaccine Productions Based on Insect Cells and the Baculovirus Expression Vector System: Influenza as Case Study

inferred← citeshttps://doi.org/10.1007/10_2020_132openalex-snapshot

Impact of Protein Glycosylation on the Design of Viral Vaccines

inferred← citeshttps://doi.org/10.1007/82_2020_228openalex-snapshot

Protein and Peptide Nanocluster Vaccines

inferred← citeshttps://doi.org/10.1007/82_2021_232openalex-snapshot

Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan Parasites

inferred← citeshttps://doi.org/10.1007/978-1-0716-1892-9_16openalex-snapshot

Current Prospects in Peptide-Based Subunit Nanovaccines

inferred← citeshttps://doi.org/10.1007/978-1-0716-1892-9_8openalex-snapshot

Developments in Vaccine Adjuvants

inferred← citeshttps://doi.org/10.1007/978-1-4939-3043-2_14openalex-snapshot

Production of Virus-Like Particles for Vaccination

inferred← citeshttps://doi.org/10.1007/978-1-4939-3387-7_7openalex-snapshot

Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies

inferred← citeshttps://doi.org/10.1007/978-1-4939-3389-1_27openalex-snapshot

Formulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates

inferred← citeshttps://doi.org/10.1007/978-1-4939-3389-1_29openalex-snapshot

Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine Assessments

inferred← citeshttps://doi.org/10.1007/978-1-4939-3389-1_37openalex-snapshot

Purification of Virus-Like Particles (VLPs) from Plants

inferred← citeshttps://doi.org/10.1007/978-1-4939-7312-5_10openalex-snapshot

Large-Scale Transient Transfection of Suspension Mammalian Cells for VLP Production

inferred← citeshttps://doi.org/10.1007/978-1-4939-9024-5_14openalex-snapshot

Guidelines for Small-Scale Production and Purification of Hepatitis B Surface Antigen Virus-Like Particles from Recombinant Pichia pastoris

inferred← citeshttps://doi.org/10.1007/978-3-030-61021-0_4openalex-snapshot

Nanovaccine: A Modern Approach to Vaccinology

inferred← citeshttps://doi.org/10.1007/978-3-030-71165-8_29openalex-snapshot

Vaccines for Emerging Viruses—A Comprehensive Update

inferred← citeshttps://doi.org/10.1007/978-3-030-78338-9_1openalex-snapshot

The New Frontier in Medicine at the Convergence of Nanotechnology and Immunotherapy

inferred← citeshttps://doi.org/10.1007/978-3-031-28489-2_1openalex-snapshot

Bioprocessing and Analytical Development for Virus-Based Therapeutics

inferred← citeshttps://doi.org/10.1007/978-3-031-28489-2_17openalex-snapshot

Recent Advancements and Challenges in Recombinant Expression for Commercial Production of Virus-Like Particles (VLPs)

inferred← citeshttps://doi.org/10.1007/978-3-031-35395-6_16openalex-snapshot

Green Nanotechnology Approaches in Vaccinology: Advantages and Disadvantages in Biomedical Sciences

inferred← citeshttps://doi.org/10.1007/978-3-031-35395-6_17openalex-snapshot

Clinical Applications of Nanovaccine Formulation Technology Market Research

inferred← citeshttps://doi.org/10.1007/978-3-031-77911-4_33openalex-snapshot

A Review on Conventional and Emerging Methods in Vaccinology: A Case Study on COVID-19

inferred← citeshttps://doi.org/10.1007/978-3-031-77911-4_8openalex-snapshot

RNA Viruses and Vaccine Development

inferred← citeshttps://doi.org/10.1007/978-3-319-24244-6_8openalex-snapshot

Insect Biotechnology

inferred← citeshttps://doi.org/10.1007/978-3-319-39196-0_5openalex-snapshot

Assembly, Engineering and Applications of Virus-Based Protein Nanoparticles

inferred← citeshttps://doi.org/10.1007/978-3-319-61343-7_9openalex-snapshot

Preventive, Diagnostic and Therapeutic Applications of Baculovirus Expression Vector System

inferred← citeshttps://doi.org/10.1007/978-3-7091-1419-3_8openalex-snapshot

Virus-like Particle Vaccines for Norovirus Gastroenteritis

inferred← citeshttps://doi.org/10.1007/978-94-007-4543-8_7openalex-snapshot

Liposomes and Other Nanoparticles as Cancer Vaccines and Immunotherapeutics

inferred← citeshttps://doi.org/10.1007/978-94-007-6552-8_21openalex-snapshot

Design of Novel Vaccines Based on Virus-Like Particles or Chimeric Virions

inferred← citeshttps://doi.org/10.1007/978-981-15-1045-8_18openalex-snapshot

Current Advances in Multi-Epitope Viral Vaccines Development and Research

inferred← citeshttps://doi.org/10.1007/978-981-16-1610-5_14openalex-snapshot

Nanotechnology in Prophylaxis of Viral Livestock Diseases

inferred← citeshttps://doi.org/10.1007/978-981-19-3979-2_8openalex-snapshot

Recombinant Vaccines: The Revolution Ahead

inferred← citeshttps://doi.org/10.1007/978-981-19-7911-8_11openalex-snapshot

Yeast Cell Factory for Production of Biomolecules

inferred← citeshttps://doi.org/10.1007/978-981-19-8249-1_11openalex-snapshot

Emerging Trends, Challenges, and Opportunities in Protein Therapeutics

inferred← citeshttps://doi.org/10.1007/978-981-95-1426-7_17openalex-snapshot

COVID-19 Vaccine: Classification, Development, and Clinical Status

inferred← citeshttps://doi.org/10.1007/978-981-96-0270-4_15openalex-snapshot

Enhancing Aquaculture Sustainability: Role of Alternative Antimicrobial Agents

inferred← citeshttps://doi.org/10.1007/978-981-96-0397-8_3openalex-snapshot

Nanomaterial-Based Vaccines

inferred← citeshttps://doi.org/10.1007/978-981-99-3947-3_9openalex-snapshot

The Exploitation of Recombinant DNA Technology to Induce Biologics Directed to Biocontrol

inferred← citeshttps://doi.org/10.1007/s00203-023-03629-2openalex-snapshot

An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases

inferred← citeshttps://doi.org/10.1007/s00210-025-04739-yopenalex-snapshot

Active immunization with bacteriophage AP205 VLPs results in reduced amyloid load and microgliosis in 5xFAD female mice

inferred← citeshttps://doi.org/10.1007/s00253-012-3958-7openalex-snapshot

Dengue virus-like particles: construction and application

inferred← citeshttps://doi.org/10.1007/s00253-013-5257-3openalex-snapshot

Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice

inferred← citeshttps://doi.org/10.1007/s00253-014-5787-3openalex-snapshot

Production and applications of engineered viral capsids

inferred← citeshttps://doi.org/10.1007/s00253-015-7000-8openalex-snapshot

The application of virus-like particles as vaccines and biological vehicles

inferred← citeshttps://doi.org/10.1007/s00253-015-7213-xopenalex-snapshot

Optimized production of HIV-1 virus-like particles by transient transfection in CAP-T cells

inferred← citeshttps://doi.org/10.1007/s00253-017-8605-xopenalex-snapshot

Transient gene expression optimization and expression vector comparison to improve HIV-1 VLP production in HEK293 cell lines

inferred← citeshttps://doi.org/10.1007/s00253-018-8930-8openalex-snapshot

Enhancement of HIV-1 VLP production using gene inhibition strategies

inferred← citeshttps://doi.org/10.1007/s00253-019-10038-3openalex-snapshot

Production of HIV-1-based virus-like particles for vaccination: achievements and limits

inferred← citeshttps://doi.org/10.1007/s00253-021-11331-wopenalex-snapshot

Contribution of yeast models to virus research

inferred← citeshttps://doi.org/10.1007/s00253-021-11747-4openalex-snapshot

Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications

inferred← citeshttps://doi.org/10.1007/s00253-024-13389-8openalex-snapshot

Targeted knockdown of ATM, ATR, and PDEδ increases Gag HIV-1 VLP production in HEK293 cells

inferred← citeshttps://doi.org/10.1007/s00430-016-0465-yopenalex-snapshot

Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy

inferred← citeshttps://doi.org/10.1007/s00449-022-02754-4openalex-snapshot

High-level production of recombinant HBcAg virus-like particles in a mathematically modelled P. pastoris GS115 Mut+ bioreactor process under controlled residual methanol concentration

inferred← citeshttps://doi.org/10.1007/s00705-012-1565-7openalex-snapshot

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

inferred← citeshttps://doi.org/10.1007/s00705-013-1612-zopenalex-snapshot

Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus

inferred← citeshttps://doi.org/10.1007/s00705-019-04262-5openalex-snapshot

Assembly of tomato blistering mosaic virus-like particles using a baculovirus expression vector system

inferred← citeshttps://doi.org/10.1007/s10126-022-10166-4openalex-snapshot

Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher

inferred← citeshttps://doi.org/10.1007/s10529-021-03211-0openalex-snapshot

Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2

inferred← citeshttps://doi.org/10.1007/s11033-022-07132-7openalex-snapshot

Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms

inferred← citeshttps://doi.org/10.1007/s11095-016-1979-0openalex-snapshot

Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

inferred← citeshttps://doi.org/10.1007/s11240-013-0388-xopenalex-snapshot

Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine

inferred← citeshttps://doi.org/10.1007/s11262-017-1450-2openalex-snapshot

Porcine epidemic diarrhea virus virus-like particles produced in insect cells induce specific immune responses in mice

inferred← citeshttps://doi.org/10.1007/s11262-017-1451-1openalex-snapshot

Newcastle disease virus-like particles induce dendritic cell maturation and enhance viral-specific immune response

inferred← citeshttps://doi.org/10.1007/s11427-024-2851-4openalex-snapshot

Bioprofiling and vaccine development for Zika virus

inferred← citeshttps://doi.org/10.1007/s12010-017-2447-yopenalex-snapshot

Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance Applications

inferred← citeshttps://doi.org/10.1007/s12033-012-9563-2openalex-snapshot

Protein Bodies in Nature and Biotechnology

inferred← citeshttps://doi.org/10.1007/s12033-012-9598-4openalex-snapshot

Construction and Characterization of Virus-Like Particles: A Review

inferred← citeshttps://doi.org/10.1007/s12033-019-00198-yopenalex-snapshot

Expression of Breast Cancer-Related Epitopes Targeting the IGF-1 Receptor in Chimeric Human Parvovirus B19 Virus-Like Particles

inferred← citeshttps://doi.org/10.1007/s12033-021-00366-zopenalex-snapshot

Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach

inferred← citeshttps://doi.org/10.1007/s12250-012-3241-1openalex-snapshot

Developments of subunit and VLP vaccines against influenza a virus

inferred← citeshttps://doi.org/10.1007/s12250-015-3573-8openalex-snapshot

Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles

inferred← citeshttps://doi.org/10.1007/s12250-016-3756-yopenalex-snapshot

Virus like particle-based vaccines against emerging infectious disease viruses

inferred← citeshttps://doi.org/10.1007/s12257-014-0768-zopenalex-snapshot

Production of influenza virus-like particles from stably transfected Trichoplusia ni BT1 TN-5B1-4 cells

inferred← citeshttps://doi.org/10.1007/s12274-021-3832-yopenalex-snapshot

Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform

inferred← citeshttps://doi.org/10.1007/s12274-022-5267-5openalex-snapshot

Use of stimulatory responsive soft nanoparticles for intracellular drug delivery

inferred← citeshttps://doi.org/10.1007/s13204-021-01900-wopenalex-snapshot

SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches

inferred← citeshttps://doi.org/10.1007/s13337-020-00580-4openalex-snapshot

Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives

inferred← citeshttps://doi.org/10.1007/s13337-022-00755-1openalex-snapshot

A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges

inferred← citeshttps://doi.org/10.1007/s40005-025-00795-xopenalex-snapshot

Advances in pharmaceutical formulation technologies for thermostable vaccine platforms considering patient-centered design

inferred← citeshttps://doi.org/10.1007/s40199-023-00496-6openalex-snapshot

Artificial viruses: A nanotechnology based approach

inferred← citeshttps://doi.org/10.1007/s40203-025-00550-yopenalex-snapshot

VP30 vanguard: pioneering an in-silico multi-epitope vaccine against Marburg virus

inferred← citeshttps://doi.org/10.1007/s40259-026-00767-zopenalex-snapshot

Advances in Engineered Virus-Like Particles for Genome Editing and Therapy

inferred← citeshttps://doi.org/10.1007/s44371-026-00929-6openalex-snapshot

Artificial intelligence can support the chemical design of multiepitope vaccine nanocarriers

inferred← citeshttps://doi.org/10.1016/b978-0-08-100741-9.00015-2openalex-snapshot

Artificial virus particles

inferred← citeshttps://doi.org/10.1016/b978-0-12-416020-0.00006-1openalex-snapshot

Engineered Biological Entities for Drug Delivery and Gene Therapy

inferred← citeshttps://doi.org/10.1016/b978-0-12-814357-5.00001-5openalex-snapshot

Subunit-based vaccines

inferred← citeshttps://doi.org/10.1016/b978-0-12-816662-8.00011-4openalex-snapshot

Virus like particles: fundamental concepts, biological interactions, and clinical applications

inferred← citeshttps://doi.org/10.1016/b978-0-12-819363-1.00012-0openalex-snapshot

Virus-like particles: nano-carriers in targeted therapeutics

inferred← citeshttps://doi.org/10.1016/b978-0-12-821006-2.00017-0openalex-snapshot

Recombinant Pichia pastoris and its applications in healthcare industry

inferred← citeshttps://doi.org/10.1016/b978-0-12-821406-0.00001-1openalex-snapshot

Recent developments in vaccines strategies against human viral pathogens

inferred← citeshttps://doi.org/10.1016/b978-0-12-821506-7.00020-xopenalex-snapshot

Nanocarrier-based vaccine delivery systems for synthetic peptide vaccines

inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00005-5openalex-snapshot

Vaccine Manufacturing

inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00006-2openalex-snapshot

Vaccine Manufacturing

inferred← citeshttps://doi.org/10.1016/b978-0-323-85662-1.00004-5openalex-snapshot

Recent trends in the development of vaccine technologies to combat pandemic outbreaks and challenges

inferred← citeshttps://doi.org/10.1016/b978-0-323-87763-3.00018-6openalex-snapshot

Vaccines and active immunization against cancer

inferred← citeshttps://doi.org/10.1016/b978-0-323-90248-9.00003-6openalex-snapshot

Viral-vectored vaccines against SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/b978-0-323-90792-7.00002-6openalex-snapshot

Nanovaccines delivery approaches against infectious diseases

inferred← citeshttps://doi.org/10.1016/b978-0-323-90792-7.00012-9openalex-snapshot

Nanotechnology-based approaches against COVID-19

inferred← citeshttps://doi.org/10.1016/b978-0-323-91684-4.00023-2openalex-snapshot

Current applications of biomolecules in biopharmaceuticals and drug discovery

inferred← citeshttps://doi.org/10.1016/b978-0-323-91794-0.00019-6openalex-snapshot

Emerging technologies for COVID-19, diagnosis, prevention, and management

inferred← citeshttps://doi.org/10.1016/b978-0-323-91814-5.00004-0openalex-snapshot

Immunotherapy as an emerging and promising tool against viral infections

inferred← citeshttps://doi.org/10.1016/b978-0-323-95374-0.00015-4openalex-snapshot

Vaccine development strategies and impact

inferred← citeshttps://doi.org/10.1016/b978-0-443-15378-5.00006-1openalex-snapshot

Development of a new vaccine at the laboratory scale

inferred← citeshttps://doi.org/10.1016/b978-0-443-15518-5.00014-8openalex-snapshot

Functionalized peptide and protein-based nanomaterials for cancer therapy

inferred← citeshttps://doi.org/10.1016/b978-0-443-18564-9.00014-xopenalex-snapshot

Vector-based vaccine delivery and associated immunity

inferred← citeshttps://doi.org/10.1016/b978-0-443-33639-3.00023-4openalex-snapshot

Design, development, and drug delivery applications of self-assembling nanocarriers from engineered proteins

inferred← citeshttps://doi.org/10.1016/b978-0-444-63660-7.00001-2openalex-snapshot

Biopharmaceutical Products

inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00019-7openalex-snapshot

Vaccine manufacturing

inferred← citeshttps://doi.org/10.1016/bs.apcsb.2015.08.004openalex-snapshot

Human Papillomavirus Vaccine

inferred← citeshttps://doi.org/10.1016/bs.ircmb.2022.03.006openalex-snapshot

Applications of self-replicating RNA

inferred← citeshttps://doi.org/10.1016/bs.mie.2017.06.030openalex-snapshot

Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model

inferred← citeshttps://doi.org/10.1016/j.actbio.2021.07.055openalex-snapshot

In Situ biomimetic Nanoformulation for metastatic cancer immunotherapy

inferred← citeshttps://doi.org/10.1016/j.addr.2014.10.023openalex-snapshot

Formulation and stabilization of recombinant protein based virus-like particle vaccines

inferred← citeshttps://doi.org/10.1016/j.addr.2015.03.007openalex-snapshot

Delivery strategies to enhance oral vaccination against enteric infections

inferred← citeshttps://doi.org/10.1016/j.addr.2017.04.009openalex-snapshot

Biomaterial strategies for generating therapeutic immune responses

inferred← citeshttps://doi.org/10.1016/j.addr.2018.06.025openalex-snapshot

Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases

inferred← citeshttps://doi.org/10.1016/j.addr.2020.12.012openalex-snapshot

Coiled coil-based therapeutics and drug delivery systems

inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.002openalex-snapshot

Nanocarrier vaccines for SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.014openalex-snapshot

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

inferred← citeshttps://doi.org/10.1016/j.addr.2021.02.007openalex-snapshot

Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy

inferred← citeshttps://doi.org/10.1016/j.addr.2021.113940openalex-snapshot

Scaled preparation of extracellular vesicles from conditioned media

inferred← citeshttps://doi.org/10.1016/j.addr.2021.114030openalex-snapshot

Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours

inferred← citeshttps://doi.org/10.1016/j.addr.2023.114826openalex-snapshot

Clinical delivery of circular RNA: Lessons learned from RNA drug development

inferred← citeshttps://doi.org/10.1016/j.addr.2023.115134openalex-snapshot

Overcoming biological barriers by virus-like drug particles for drug delivery

inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.02.016openalex-snapshot

A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection

inferred← citeshttps://doi.org/10.1016/j.apmt.2020.100575openalex-snapshot

Engineered hepatitis B core virus-like particle carrier for precise and personalized Alzheimer’s disease vaccine preparation via fixed-point coupling

inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.04.048openalex-snapshot

Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment

inferred← citeshttps://doi.org/10.1016/j.bbrc.2018.01.141openalex-snapshot

The level of decoy epitope in PCV2 vaccine affects the neutralizing activity of sera in the immunized animals

inferred← citeshttps://doi.org/10.1016/j.bbrc.2021.04.060openalex-snapshot

Characterization of alfalfa mosaic virus capsid protein using Cryo-EM

inferred← citeshttps://doi.org/10.1016/j.bej.2012.07.009openalex-snapshot

Reactive diafiltration for assembly and formulation of virus-like particles

inferred← citeshttps://doi.org/10.1016/j.bej.2019.107373openalex-snapshot

Production and characterization of Hantaan virus-like particles from baculovirus expression system

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2017.05.001openalex-snapshot

Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.120726openalex-snapshot

P22 virus-like particles as an effective antigen delivery nanoplatform for cancer immunotherapy

inferred← citeshttps://doi.org/10.1016/j.biopha.2022.114117openalex-snapshot

Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection

showing the first 200 of 829 · page through all 829

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.